CompuGroup Medical SE & Co. KGaA (XTRA:COP) commences share repurchases on November 26, 2021, under the program mandated by the shareholders in the Annual General Meeting held on May 19, 2021. As per the mandate, the company is authorized to repurchase its own shares, such that the company's holding in treasury does not exceed 10% of its issued share capital. The shares will be repurchased at a price not more than 10% from the company's volume weighted average share price on the stock exchange for five trading days prior to the repurchase date. The authority will expire on May 18, 2024.

On November 25, 2021, the company announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, for €37 million worth of its shares. The maximum price which may be paid for an ordinary share is an amount equal to 10% of the company's volume weighted average share price on the stock exchange for five trading days prior to the repurchase date and an amount equal to the higher of the price of the last independent trade and the highest current independent bid on the trading venues where the purchase is carried out at the relevant time. The repurchases will commence on November 26, 2021, and the program will expire on January 27, 2022.